CV Sciences (CVSI) Cash & Current Investments (2010 - 2026)
CV Sciences' (CVSI) quarterly Cash & Current Investments came in at $309000.0 in Q1 2026, down 61.95% year-on-year from $812000.0 in Q1 2025, and up 11.15% quarter-over-quarter from $278000.0 in Q4 2025.
CV Sciences (CVSI) Cash & Current Investments (2010 - 2026) Analysis & Trends
CV Sciences has disclosed Cash & Current Investments across 17 years of filings, most recently posting $309000.0 for Q1 2026.
- Cash & Current Investments for Q1 2026 came in at $309000.0, down 61.95% year-over-year; the trailing twelve-month figure through Mar 2026 was $309000.0 (down 61.95% YoY), and the FY2025 annual result was $278000.0, down 38.77% from the prior year.
- Cash & Current Investments came in at $309000.0 for Q1 2026 at CV Sciences, up from $278000.0 in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $2.4 million in Q1 2022 to a low of $278000.0 in Q4 2025.
- The 5-year median for Cash & Current Investments is $812000.0 (2025), against an average of $935588.2.
- Across the five-year window, Cash & Current Investments soared 115.55% in 2023 and sank 71.78% in 2024, its largest moves.
- CV Sciences' Cash & Current Investments stood at $611000.0 in 2022, then jumped by 115.55% to $1.3 million in 2023, then plunged by 65.53% to $454000.0 in 2024, then sank by 38.77% to $278000.0 in 2025, then increased by 11.15% to $309000.0 in 2026.
- The last three Cash & Current Investments figures came in at $309000.0 (Q1 2026), $278000.0 (Q4 2025), and $381000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | 3.74 Bn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | 1.94 Bn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 2.15 Bn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | 77.77 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 1.32 Bn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | 428.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | 511.86 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 498.58 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | 750.88 Mn |
| 10 | CV Sciences | - | - | 1.56 Mn | 309,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 309,000.00 |
| Dec 31, 2025 | 278,000.00 |
| Sep 30, 2025 | 381,000.00 |
| Jun 30, 2025 | 886,000.00 |
| Mar 31, 2025 | 812,000.00 |
| Dec 31, 2024 | 454,000.00 |
| Sep 30, 2024 | 979,000.00 |
| Jun 30, 2024 | 477,000.00 |
| Mar 31, 2024 | 662,000.00 |
| Dec 31, 2023 | 1.32 Mn |
| Sep 30, 2023 | 1.64 Mn |
| Jun 30, 2023 | 1.69 Mn |
| Mar 31, 2023 | 714,000.00 |
| Dec 31, 2022 | 611,000.00 |
| Sep 30, 2022 | 1.14 Mn |
| Jun 30, 2022 | 1.11 Mn |
| Mar 31, 2022 | 2.44 Mn |
| Dec 31, 2021 | 1.38 Mn |
| Jun 30, 2021 | 2.96 Mn |
| Mar 31, 2021 | 5.67 Mn |